These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7483659)

  • 1. Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity.
    Lewis DF; Lake BG
    Xenobiotica; 1995 Jun; 25(6):585-98. PubMed ID: 7483659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.
    Lindberg RL; Negishi M
    Nature; 1989 Jun; 339(6226):632-4. PubMed ID: 2733794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of coumarin by human P450s: a molecular modelling study.
    Lewis DF; Ito Y; Lake BG
    Toxicol In Vitro; 2006 Mar; 20(2):256-64. PubMed ID: 16157466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.
    Ridderström M; Masimirembwa C; Trump-Kallmeyer S; Ahlefelt M; Otter C; Andersson TB
    Biochem Biophys Res Commun; 2000 Apr; 270(3):983-7. PubMed ID: 10772937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins.
    Domanski TL; He YQ; Scott EE; Wang Q; Halpert JR
    Arch Biochem Biophys; 2001 Oct; 394(1):21-8. PubMed ID: 11566023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding.
    Haining RL; Jones JP; Henne KR; Fisher MB; Koop DR; Trager WF; Rettie AE
    Biochemistry; 1999 Mar; 38(11):3285-92. PubMed ID: 10079071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
    Lewis DF; Lake BG
    Xenobiotica; 2002 Jul; 32(7):547-61. PubMed ID: 12162851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and alpha-naphthoflavone stimulation.
    Domanski TL; Liu J; Harlow GR; Halpert JR
    Arch Biochem Biophys; 1998 Feb; 350(2):223-32. PubMed ID: 9473295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation.
    Lisurek M; Simgen B; Antes I; Bernhardt R
    Chembiochem; 2008 Jun; 9(9):1439-49. PubMed ID: 18481342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.
    Iwasaki M; Lindberg RL; Juvonen RO; Negishi M
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):569-73. PubMed ID: 8484736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S; Attias R; Dansette PM; Mansuy D
    Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic side chain requirements for lauric acid and progesterone hydroxylation at amino acid 113 in cytochrome P450 2C2, a potential determinant of substrate specificity.
    Straub P; Johnson EF; Kemper B
    Arch Biochem Biophys; 1993 Nov; 306(2):521-7. PubMed ID: 8215458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.
    Wong HL; Murphy SE; Hecht SS
    Chem Res Toxicol; 2005 Jan; 18(1):61-9. PubMed ID: 15651850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis.
    He YA; He YQ; Szklarz GD; Halpert JR
    Biochemistry; 1997 Jul; 36(29):8831-9. PubMed ID: 9220969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1.
    Zheng YM; Fisher MB; Yokotani N; Fujii-Kuriyama Y; Rettie AE
    Biochemistry; 1998 Sep; 37(37):12847-51. PubMed ID: 9737862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
    Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase).
    Jones BC; Hawksworth G; Horne VA; Newlands A; Morsman J; Tute MS; Smith DA
    Drug Metab Dispos; 1996 Feb; 24(2):260-6. PubMed ID: 8742240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily.
    Lewis DF; Dickins M; Weaver RJ; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1998 Mar; 28(3):235-68. PubMed ID: 9574814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.